AGMB AGMB
Company Profile ↓Company Overview
AGMB (AGMB) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -2.25% |
| 6 Months: | - |
| 3 Months: | +14.56% |
| 1 Month: | +7.83% |
- Price vs 50-DMAAbove
- RSI (14)61.46 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 11.81M | 16.53M |
| Operating Income | -11.81M | -16.53M |
| EBITDA | -11.80M | -17.62M |
| Interest Expense | -155.00K | -139.00K |
| Pretax Income | -11.73M | -17.40M |
| Tax Provision | 4.00K | 0 |
| Net Income | -11.73M | -17.40M |
| Diluted EPS | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 22.63M | 31.19M | 48.02M | 59.27M |
| Operating Income | -22.63M | -31.19M | -48.02M | -59.27M |
| EBITDA | -10.74M | -11.88M | -45.88M | -62.27M |
| Interest Expense | 45.00K | 31.00K | 67.00K | 60.00K |
| Pretax Income | -10.81M | -12.01M | -46.26M | -62.55M |
| Tax Provision | -2.66M | -619.00K | 4.00K | 0 |
| Net Income | -8.14M | -11.39M | -46.27M | -62.55M |
| Diluted EPS | -0.22 | -0.31 | -1.28 | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AGMB
We Think AgomAb Therapeutics (NASDAQ:AGMB) Can Afford To Drive Business Growth - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxQcnhrQnRJQXVVckIyQVJIazg4Q2tUSzJDa1FmMUx1YjliYUNTVE9sazNFSzVuWERBVGptenM0R3NDZGpmM2hNMGpWRUVQc2JXQTB4Yjk3WHBicklab2xObllNRVFxOV8yWEtZOFhPMEg3V1I5dlJRZWtBdG5DYWdpbFNld1dncG1QOHJ6bk…
Enterprise value to revenue forward of AgomAb Therapeutics NV – NASDAQ:AGMB - TradingView
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPNU9oNE9sT3lrTjBhem5TQm5WLTNzNTRPX2Z5R1Ftcmt6OVd2U0s4aXVkVm9TUEVnTmZJdUlqWXdxVlRBM3pHdkJJSGRqdEFhbVV6a3o5MlJjTGV1QnhyX19wSzM2WG02TUFjRUluZzVVSFFDbmVsN3BuRFJVbVFuWjVrWWg2VkQwMEVKS0…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9NVTEtZTFFaVprY0tpX08wSTdyVGRnLXlYNTJDazlHS0hqVDk0Y2hPRks5M19xb21jZWV6SjFBcFU3TzBNT3dYaUJ6REF4Y0t4?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Is AgomAB Therapeutics NV (AGMB) Stock a Biotech Opportunity With Targeted Tissue Therapy Potential? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNV1otalZiZW9pc2Q5YnB0aGE1ZGZaX2VlMVlna1Qzank5VWRWckRwdERrelJKcEhRYl9kOHJrZUdrWi0ta2lGSExGTUw0MFcyZG9qX3NWYm9nUHpFdHpxbmp4cHhjVWd5WlE5eEVNQk9lSUNNSVRNWE1LcFlPbGwybm1YUzdUeGk2QVB2UX…
AgomAb Therapeutics: High Risk, High Reward Stock (NASDAQ:AGMB) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOaW5WMDMwd3R6dXE0eVdUdEJoTFNrX3lPdG9wcXNtazJqRGZMeTlBQzc0SExyNVFXNmU4N3RpaHVxRlVDeU1sRTAxZmdPaTFtUDFLRlB3OEhIMm5MVW1iUjlxb1dkRVM1aUNjZXB4OHNRZEt0MU5ydG10NWg0a1Jja1Q3emNzUnR0RkdGaF…
H.C. Wainwright Maintains AgomAb Therapeutics(AGMB.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRFRfNWZydURPbXNsZWhRMVJVXzU3eEwtSjFVaWQ5S3ZOOGN0cmZlSDhkZ25kR3lOZnZnWmROSUtrUWRYalV4YUZMWmNlbW0yQm9NYlJkOTdKcEo0VE9CSGhObUtLaFJHOGN6UDM1cHN5YjVMZ1U0amNfT0NsYTdreW5qb21mdGRPZDhWME…
AGMB — Frequently Asked Questions
What is the current share price of AGMB?
As of 2026-08-05 17:25 PDT, AGMB trades at $14.32 on NASDAQ/NYSE. Its 52-week range is $9.61 to $17.82.
What is the P/E ratio of AGMB?
AGMB trades at a trailing price-to-earnings (P/E) ratio of -11.22.
Is AGMB a good stock to buy?
This page provides a data-driven analysis of AGMB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.